1. Title 21 CFR Part 11 Definition
Title 21 CFR Part 11 is a regulation issued by the U.S. Food and Drug Administration (FDA) that outlines the criteria for electronic records and electronic signatures to be considered equivalent to paper records and handwritten signatures. This regulation applies to industries regulated by the FDA, such as pharmaceuticals, biotechnology, and medical devices, and ensures that electronic records are trustworthy, reliable, and compliant with legal standards.
2. Why Is Title 21 CFR Part 11 Important?
- Regulatory Compliance: Compliance with Title 21 CFR Part 11 ensures that electronic records and signatures are legally accepted by the FDA and meet industry standards.
- Data Integrity: The regulation ensures that electronic records are secure, accurate, and tamperproof, maintaining the integrity of critical data in regulated industries.
- Auditability: Title 21 CFR Part 11 requires detailed audit trails for electronic records, ensuring that all actions related to the data are documented and traceable.
- Non-Repudiation: Electronic signatures under Part 11 are legally binding, ensuring that signers cannot deny their involvement in the signing process or the authenticity of the record.
3. Key Components of Title 21 CFR Part 11
- Electronic Signature Requirements: Part 11 defines the requirements for electronic signatures to be legally equivalent to handwritten signatures, including authentication and security controls.
- Audit Trails: The regulation mandates the use of audit trails to record all actions taken on electronic records, ensuring full traceability of data access and modifications.
- Data Security: Title 21 CFR Part 11 requires robust security measures, such as encryption and access controls, to protect electronic records from tampering or unauthorized access.
- Validation: The regulation requires that systems managing electronic records and signatures be validated to ensure they function correctly and consistently.
4. Certinal eSign’s Title 21 CFR Part 11 Features
- Compliant Electronic Signatures: Certinal supports electronic signatures that comply with the requirements of Title 21 CFR Part 11, ensuring their legal equivalency to handwritten signatures in FDA-regulated industries.
- Audit Trail Generation: Certinal generates detailed audit trails for all actions related to electronic records, meeting the traceability requirements of Part 11.
- Data Integrity and Security: Certinal uses encryption, access controls, and other security measures to protect electronic records, ensuring compliance with Part 11’s data security standards.
- System Validation Support: Certinal provides features to help organizations validate their eSignature and electronic records systems, ensuring compliance with FDA regulations.